A randomized controlled trial comparing incidences of postoperative nausea and vomiting after laparoscopic cholecystectomy for preoperative intravenous fluid loading, ondansetron, and control groups in a regional hospital setting in a developing country

Mingkwan Wongyingsinn, Pechprapa Peanpanich, Sirirat Charoensawan, Mingkwan Wongyingsinn, Pechprapa Peanpanich, Sirirat Charoensawan

Abstract

Background: Postoperative nausea and vomiting (PONV) is a common complication in inpatient and outpatient settings. Multimodal approaches have been pursued to minimize this undesirable outcome. Despite consensus guidelines for the management of PONV have been updated and published for many years, data from our pilot study showed that patients with high-risk surgeries for PONV, laparoscopic cholecystectomy (LC), still hardly received perioperative PONV prophylaxis. This study aimed to compare the incidences of PONV in adult patients undergoing elective LC who were administered preoperative intravenous fluid loading, ondansetron, or neither fluid nor ondansetron in the setting of a regional hospital in a developing country.

Methods: The study was designed as a prospective randomized controlled trial. The total of 171 patients was allocated to three groups: one received fluid loading with Ringer's lactate solution before the operation; the second received ondansetron; and the third group received neither.

Results: In total, 156 patients were analyzed. Their demographic data, history of motion sickness/PONV, and smoking status were not significantly different. The overall incidences of PONV within 24 hours of surgery were 29.1% in the fluid group, 18.4% in the ondansetron group, and 25% in the control group, but the difference was not statistically significant (P = .442). In subgroup analysis, the incidences of PONV and PON in patients younger than 50 years old were significantly different among the three groups (P = .008). A post hoc analysis showed that patients under 50 years in the ondansetron group had significantly lower incidences of PONV and PON than those in the control and fluid groups. However, the incidences of morphine consumption and dizziness in the ondansetron group were significantly higher than those of the two other groups.

Conclusions: Neither the preoperative intravenous fluid loading nor the ondansetron affected PONV in patients aged 50 and older undergoing LC, compared with control. Ondansetron was beneficial for PON prophylaxis in patients under the age of 50, whereas preoperative intravenous fluid loading was considered a risk factor for PON in this population.

Trial registration: ClinicalTrials.gov NCT03141645.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1.
Figure 1.
Consort flow diagram.

References

    1. Gan TJ, Belani KG, Bergese S, et al. . Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131:411–48.
    1. Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011;107:i27–40.
    1. Pierre S, Whelan R. Nausea and vomiting after surgery. Continuing education in anaesthesia. Crit Care Pain. 2013;13:28–32.
    1. Apfel CC, Korttila K, Abdalla M, et al. . A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–51.
    1. Gan TJ. Postoperative nausea and vomiting – can it be eliminated? JAMA. 2002;287:1233–6.
    1. Thune A, Appelgren L, Haglind E. Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg. 1995;161:265–8.
    1. Nathan N. Management of postoperative nausea and vomiting: the 4th consensus guidelines. Anesth Analg. 2020;131:410.
    1. Liberman MA, Howe S, Lane M. Ondansetron versus placebo for prophylaxis of nausea and vomiting in patients undergoing ambulatory laparoscopic cholecystectomy. Am J Surg. 2000;179:60–2.
    1. McCracken G, Houston P, Lefebvre G. Society of obstetricians and gynecologists of Canada. Guideline for the management of postoperative nausea and vomiting. J Obstet Gynaecol Can. 2008;30:600–7, 608.
    1. Chandrakala R, Vijayashankara CN, Kumar KK, et al. . Ondansetron induced fatal ventricular tachycardia. Indian J Pharmacol. 2008;40:186–7.
    1. Mehra KK, Gogtay NJ, Ainchwar R, et al. . Hypersensitivity to intravenous ondansetron: a case report. J Med Case Re. 2008;2:274.
    1. Yavuz MS, Kazanci D, Turan S, et al. . Investigation of the effects of preoperative hydration on the postoperative nausea and vomiting. Biomed Res Int. 2014;2014:302747.
    1. Elgueta MF, Echevarría GC, De la Fuente N, et al. . Effect of intravenous fluid therapy on postoperative vomiting in children undergoing tonsillectomy. Br J Anaesth. 2013;110:607–14.
    1. Apfel CC, Meyer A, Orhan-Sungur M, et al. . Supplemental intravenous crystalloids for the prevention of postoperative nausea and vomiting: quantitative review. Br J Anaesth. 2012;108:893–902.
    1. Lambert KG, Wakim JH, Lambert NE. Preoperative fluid bolus and reduction of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery. AANA J. 2009;77:110–4.
    1. Turkistani A, Abdullah K, Manaa E, et al. . Effect of fluid preloading on postoperative nausea and vomiting following laparoscopic cholecystectomy. Saudi J Anaesth. 2009;3:48–52.
    1. Maharaj CH, Kallam SR, Malik A, et al. . Preoperative intravenous fluid therapy decreases postoperative nausea and pain in high risk patients. Anesth Analg. 2005;100:675–82.
    1. Hooper VD. SAMBA consensus guidelines for the management of postoperative nausea and vomiting: an executive summary for perianesthesia nurses. J Perianesth Nurs. 2015;30:377–82.
    1. Moghadamyeghaneh Z, Badami A, Masi A, et al. . Unplanned readmission after outpatient laparoscopic cholecystectomy. HPB (Oxford). 2020;22:702–9.
    1. Erhan Y, Erhan E, Aydede H, et al. . Ondansetron, granisetron, and dexamethasone compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a randomized placebo-controlled study. Surg Endosc. 2008;22:1487–92.
    1. Bisgaard T, Klarskov B, Kehlet H, et al. . Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:651–60.
    1. Sridharan K, Sivaramakrishnan G. Drugs for preventing post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: network meta-analysis of randomized clinical trials and trial sequential analysis. Int J Surg. 2019;69:1–12.
    1. Ali SZ, Taguchi A, Holtmann B, Kurz A. Effect of supplemental pre-operative fluid on postoperative nausea and vomiting. Anaesthesia. 2003;58:780–4.
    1. Spencer EM. Intravenous fluids in minor gynaecological surgery. Their effect on postoperative morbidity. Anaesthesia. 1988;43:1050–1.
    1. Keane PW, Murray PF. Intravenous fluids in minor surgery. Their effect on recovery from anaesthesia. Anaesthesia. 1986;41:635–7.
    1. McCaul C, Moran C, O’Cronin D, et al. . Intravenous fluid loading with or without supplementary dextrose does not prevent nausea, vomiting and pain after laparoscopy. Can J Anaesth. 2003;50:440–4.
    1. Moon YE, Joo J, Kim JE, et al. . Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. Br J Anaesth. 2012;108:417–22.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する